Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v2.4.0.8
Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Cash flows from operating activities:    
Net income $ 249,124 $ 3,241,944
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 134,433 132,910
Non-cash interest expense, net of amortization of premium 10,932 21,031
Provision for doubtful accounts 20,153 14,879
Amortization of deferred income related to equity method investment (1,388) (1,388)
Loss on extinguishment of debt and credit facilities, net 16,377 25,621
(Gain) loss on unconsolidated entity investments, net (1,382) 3,469
Dividend received from unconsolidated entity investment 13,217 0
Loss on disposal of assets 126 488
Share-based payment expense 30,012 28,869
Deferred income taxes 159,191 (2,995,542)
Other non-cash purchase price adjustments (137,889) (147,328)
Changes in operating assets and liabilities:    
Accounts receivable (15,214) (26,879)
Receivables from distributors (6,863) (12,259)
Inventory 8,649 (173)
Related party assets 205 6,813
Prepaid expenses and other current assets (28,317) (39,308)
Other long-term assets 1,353 16,579
Accounts payable and accrued expenses (69,310) (51,596)
Accrued interest 3,868 (7,434)
Deferred revenue 59,116 79,288
Related party liabilities 1,171 1,501
Other long-term liabilities (5,543) 2,238
Net cash provided by operating activities 442,021 293,723
Cash flows from investing activities:    
Additions to property and equipment (62,980) (48,944)
Net cash used in investing activities (62,980) (48,944)
Cash flows from financing activities:    
Proceeds from exercise of stock options 21,658 38,671
Payment of premiums on redemption of debt (14,719) (19,211)
Repayment of long-term borrowings (283,180) (169,899)
Long-term borrowings, net of costs 1,136,640 0
Common stock repurchased and retired (1,108,616) 0
Net cash used in financing activities (248,217) (150,439)
Net increase in cash and cash equivalents 130,824 94,340
Cash and cash equivalents at beginning of period 520,945 773,990
Cash and cash equivalents at end of period 651,769 868,330
Cash paid during the period for:    
Interest, net of amounts capitalized 76,540 121,480
Non-cash investing and financing activities:    
Capital lease obligations incurred to acquire assets 0 12,781
Conversion of Series B preferred stock to common stock 1,293 0
Conversion of 7% Exchangeable Notes to common stock, net of debt issuance and deferred financing costs 45,097 0
Goodwill reduced for the exercise and vesting of certain stock awards 0 19,183
Treasury stock not yet settled $ 35,173 $ 0